mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.2 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.2 |
mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.2 |
mRNA |
BRD-K96970199 |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.2 |
mRNA |
CHEMBL1222381 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.2 |
mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.2 |
mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.2 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |